We further examined the effects of treatment on the proteins FDX1 and DLAT, which are closely associated with cuproptosis, and accordingly observed a notable upregulation of FDX1 expression in all three assessed HCC cell lines following treatment with elesclomol-Cu (Figures 2A-F). The gene discussed is DLAT; the disease is hepatocellular carcinoma.